100 U/ml
Trade Name
Cytotect CP Biotest
Solution for injection
Request Type
New Registration
Drug Type
Biological Drug
Approval Date
SFDA Approved Use
Prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.
The concomitant use of adequate virostatic agents should be considered for CMV-prophylaxis.
The concomitant use of adequate virostatic agents should be considered for CMV-prophylaxis.